News
-
-
-
-
PRESS RELEASE
AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024
AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024, showing promising results in phase 2B/3 study AB07002 -
-
REGULATED PRESS RELEASE
ENGIE reaches more than 1.8 GW of Battery Energy Storage Systems installed capacity in the U.S., of which 1 GW added since January 2024
ENGIE reaches 1.8 GW of Battery Energy Storage Systems in the U.S., adding 1 GW since January 2024. ENGIE strengthens position as a leader in energy transition, focusing on grid flexibility and renewable integration -
-
-
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares on September 16 to September 20, 2024